Status:
COMPLETED
Blood Pressure Lowering Effect of B-vitamins in Adults With a Genetic Pre-disposition to Elevated Blood Pressure.
Lead Sponsor:
University of Ulster
Conditions:
Blood Pressure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Approximately 12% of the world's population have a have a common C677T polymorphism in the gene encoding the folate metabolising enzyme, methylenetetrahydrofolate reductase (MTHFR). Homozygosity for t...
Eligibility Criteria
Inclusion
- MTHFR 677TT genotype, aged at least 18 years old
Exclusion
- Taking supplements containing B-vitamins
- Pregnant or planning to conceive
- Taking medications interfering with folate metabolism
- Renal or gastrointestinal disease
Key Trial Info
Start Date :
June 28 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2019
Estimated Enrollment :
2564 Patients enrolled
Trial Details
Trial ID
NCT04278378
Start Date
June 28 2011
End Date
August 15 2019
Last Update
June 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Human Intervention Studies Unit, Ulster University
Coleraine, Co.Londonderry, United Kingdom, BT52 1SA